Cephalosporin Allergy Clinical Trial
Official title:
The Results of Skin Testing and The Detection of Cytokine Secretion From Drug Specific Peripheral Blood Mononuclear Cells Using ELISPOT Assay in the Diagnosis of Nonimmediate Reactions to Cephalosporins
Verified date | October 2011 |
Source | Chulalongkorn University |
Contact | n/a |
Is FDA regulated | No |
Health authority | Thailand: Ethical Committee |
Study type | Observational |
This study aims to compare the results of skin testing and ELISPOT assay in patients with a history of non-immediate reactions to cephalosporins
Status | Completed |
Enrollment | 28 |
Est. completion date | May 2011 |
Est. primary completion date | May 2011 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: 1. Patients with a history of non-immediate hypersensitivity reactions to cephalosporins 2. At least 18 years of age Exclusion Criteria: 1. Suffering from severe systemic disease/ in bad health 2. Being pregnant 3. Patients with a history of immediate reactions to cephalosporin |
Observational Model: Case-Only, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
Thailand | Faculty of Medicine, Chulalongkorn University | Bangkok |
Lead Sponsor | Collaborator |
---|---|
Chulalongkorn University |
Thailand,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The skin testing results of Cephalosporin skin test compared to ELISPOT assay | 1 year | Yes | |
Secondary | The result of cross reactivity between Cephalosporins and other Betalactams determined by skin testing and ELISPOT assay | 1 year | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06406114 -
Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing
|
Phase 2 |